Routine evaluation of meibomian glands, starting in childhood, is crucial for identifying and managing this progressive disease before it leads to long-term ocular surface issues.

The lack of FDA-approved therapies for Ocular Rosacea may highlight a high level of risk and uncertainty associated with developing ... Meibomian Gland Disease (MGD) further underscore the utility ...